Skip to main content
Erschienen in: Acta Neurologica Belgica 1/2017

01.11.2016 | Original Article

Combined brain and anterior visual pathways’ MRIs assist in early identification of neuromyelitis optica spectrum disorder at onset of optic neuritis

verfasst von: D. Buch, J. Savatovsky, O. Gout, C. Vignal, R. Deschamps

Erschienen in: Acta Neurologica Belgica | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Acute optic neuritis (ON) is the initial presentation in half of neuromyelitis optica spectrum disorder (NMO-SD) cases. Our objective was to evaluate accuracy of combined MRIs of the anterior visual pathways and of the brain to correctly identify NMO-SD among patients with acute ON. We performed a retrospective study on patients with acute ON in NMO-SD (16 episodes) and first-event non-NMO-SD (32 episodes). All MRIs included exams of the brain and anterior visual pathways using T2-weighted and post-gadolinium T1-weighted coronal thin slices. Images were reviewed by a neuroradiologist who was blinded to the final diagnosis. There were no multiple sclerosis (MS)-like lesions with dissemination in space (DIS) with NMO-SD (0 vs. 53%, p < 0.01). Non-NMO-SD ON usually spared the chiasma (3 vs. 44%, p < 0.01) and the optic tracts (0 vs. 19%, p < 0.01). Optic nerve lesions were longer [median (range) 26 mm (14–64) vs. 13 mm [8–36], p < 0.01] and the number of segments involved higher (3 [1–8] vs. 1 [1–4], p < 0.01) in NMO-SD. Bilateral optic nerve involvement, or involvement of ≥3 segments, or involvement of the chiasma, or optic tracts in the absence of MS-like lesions with DIS were suggestive of NMO-SD with a sensitivity of 69% (CI 95% 41–89) and a specificity of 97% (CI 95% 84–99) (p < 0.01). Combining brain and anterior visual pathways’ MRIs seems efficient for detecting acute ON patients who are at high risk for NMO-SD.
Literatur
2.
Zurück zum Zitat Jarius S, Ruprecht K, Wildemann B et al (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica. A multicentre study of 175 patients. J Neuroinflamm 19(9):14 Jarius S, Ruprecht K, Wildemann B et al (2012) Contrasting disease patterns in seropositive and seronegative neuromyelitis optica. A multicentre study of 175 patients. J Neuroinflamm 19(9):14
3.
Zurück zum Zitat Merle H, Olindo S, Bonnan M et al (2007) Natural history of the visual impairment of relapsing neuromyelitis optica. Ophthalmology 114(4):810–815CrossRefPubMed Merle H, Olindo S, Bonnan M et al (2007) Natural history of the visual impairment of relapsing neuromyelitis optica. Ophthalmology 114(4):810–815CrossRefPubMed
4.
Zurück zum Zitat Papais-Alvarenga RM, Carellos SC, Alvarenga MP, Holander C, Bichara RP, Thuler LC (2008) Clinical course of optic neuritis in patients with relapsing neuromyelitis optica. Arch Ophthalmol 126(1):12–16CrossRefPubMed Papais-Alvarenga RM, Carellos SC, Alvarenga MP, Holander C, Bichara RP, Thuler LC (2008) Clinical course of optic neuritis in patients with relapsing neuromyelitis optica. Arch Ophthalmol 126(1):12–16CrossRefPubMed
5.
Zurück zum Zitat Merle H, Olindo S, Jeannin S et al (2012) Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica. Arch Ophthalmol 130(7):858–862CrossRefPubMed Merle H, Olindo S, Jeannin S et al (2012) Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica. Arch Ophthalmol 130(7):858–862CrossRefPubMed
6.
Zurück zum Zitat Abboud H, Petrak A, Mealy M, Sasidharan S, Siddique L, Levy M (2016) Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange. Mult Scler 22(2):185–192CrossRefPubMed Abboud H, Petrak A, Mealy M, Sasidharan S, Siddique L, Levy M (2016) Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange. Mult Scler 22(2):185–192CrossRefPubMed
7.
Zurück zum Zitat Bonnan M, Valentino R, Olindo S, Mehdaoui H, Smadja D, Cabre P (2009) Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder. Mult Scler 15(4):487–492CrossRefPubMed Bonnan M, Valentino R, Olindo S, Mehdaoui H, Smadja D, Cabre P (2009) Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder. Mult Scler 15(4):487–492CrossRefPubMed
8.
Zurück zum Zitat Trebst C, Jarius S, Berthele A et al (2014) Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS); Neuromyelitis Optica Study Group (NEMOS). J Neurol 261(1):1–16CrossRefPubMed Trebst C, Jarius S, Berthele A et al (2014) Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS); Neuromyelitis Optica Study Group (NEMOS). J Neurol 261(1):1–16CrossRefPubMed
9.
Zurück zum Zitat Petzold A, Wattjes MP, Costello F et al (2014) The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol 10(8):447–458CrossRefPubMed Petzold A, Wattjes MP, Costello F et al (2014) The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol 10(8):447–458CrossRefPubMed
10.
Zurück zum Zitat Jarius S, Frederikson J, Waters P et al (2010) Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci 298(1–2):158–162CrossRefPubMed Jarius S, Frederikson J, Waters P et al (2010) Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis. J Neurol Sci 298(1–2):158–162CrossRefPubMed
11.
Zurück zum Zitat Bizzoco E, Lolli F, Repice AM et al (2009) Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol 256(11):1891–1898CrossRefPubMed Bizzoco E, Lolli F, Repice AM et al (2009) Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol 256(11):1891–1898CrossRefPubMed
12.
Zurück zum Zitat Marignier R, Bernard-Valnet R, Giraudon P et al (2013) Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity. Neurology 80(24):2194–2200CrossRefPubMed Marignier R, Bernard-Valnet R, Giraudon P et al (2013) Aquaporin-4 antibody-negative neuromyelitis optica: distinct assay sensitivity-dependent entity. Neurology 80(24):2194–2200CrossRefPubMed
13.
Zurück zum Zitat Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10):1485–1489CrossRefPubMed Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66(10):1485–1489CrossRefPubMed
14.
Zurück zum Zitat Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177–189CrossRefPubMedPubMedCentral Wingerchuk DM, Banwell B, Bennett JL et al (2015) International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85(2):177–189CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–302CrossRefPubMedPubMedCentral Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–302CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Petzold A, Plant GT (2014) Diagnosis and classification of autoimmune optic neuropathy. Autoimmun Rev 13(4–5):539–545CrossRefPubMed Petzold A, Plant GT (2014) Diagnosis and classification of autoimmune optic neuropathy. Autoimmun Rev 13(4–5):539–545CrossRefPubMed
17.
Zurück zum Zitat Storoni M, Davagnanam I, Radon M, Siddiqui A, Plant GT (2013) Distinguishing optic neuritis in neuromyelitis optica spectrum disease from multiple sclerosis: a novel magnetic resonance imaging scoring system. J Neuroophthalmol 33(2):123–127CrossRefPubMed Storoni M, Davagnanam I, Radon M, Siddiqui A, Plant GT (2013) Distinguishing optic neuritis in neuromyelitis optica spectrum disease from multiple sclerosis: a novel magnetic resonance imaging scoring system. J Neuroophthalmol 33(2):123–127CrossRefPubMed
19.
Zurück zum Zitat Khanna S, Sharma A, Huecker J, Gordon M, Naismith RT, Van Stavern GP (2012) Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis. J Neuroophthalmol 32(3):216–220CrossRefPubMed Khanna S, Sharma A, Huecker J, Gordon M, Naismith RT, Van Stavern GP (2012) Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis. J Neuroophthalmol 32(3):216–220CrossRefPubMed
20.
Zurück zum Zitat Pula JH, Kattah JC, Keung B, Wang H, Daily J (2014) Longitudinally extensive optic neuritis in neuromyelitis optica spectrum disorder. J Neurol Sci 345(1–2):209–212CrossRefPubMed Pula JH, Kattah JC, Keung B, Wang H, Daily J (2014) Longitudinally extensive optic neuritis in neuromyelitis optica spectrum disorder. J Neurol Sci 345(1–2):209–212CrossRefPubMed
21.
Zurück zum Zitat Akaishi T, Sato DK, Nakashima I et al (2016) MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study. J Neurol Neurosurg Psychiatry 87(4):446–448CrossRefPubMed Akaishi T, Sato DK, Nakashima I et al (2016) MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study. J Neurol Neurosurg Psychiatry 87(4):446–448CrossRefPubMed
22.
Zurück zum Zitat Mealy MA, Whetstone A, Orman G, Izbudak I, Calabresi PA, Levy M (2015) Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis. J Neurol Sci 355(1–2):59–63CrossRefPubMedPubMedCentral Mealy MA, Whetstone A, Orman G, Izbudak I, Calabresi PA, Levy M (2015) Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis. J Neurol Sci 355(1–2):59–63CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Akaishi T, Nakashima I, Takeshita T, Mugikura S, Sato DK, Takahashi T et al (2016) Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica. J Neuroimmunol 15(293):28–33CrossRef Akaishi T, Nakashima I, Takeshita T, Mugikura S, Sato DK, Takahashi T et al (2016) Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica. J Neuroimmunol 15(293):28–33CrossRef
24.
Zurück zum Zitat Ramanathan S, Prelog K, Barnes EH et al (2016) Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler 22(4):470–482CrossRefPubMed Ramanathan S, Prelog K, Barnes EH et al (2016) Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler 22(4):470–482CrossRefPubMed
25.
Zurück zum Zitat Kupersmith MJ, Alban T, Zeiffer B, Lefton D (2002) Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. Brain 125(Pt 4):812–822CrossRefPubMed Kupersmith MJ, Alban T, Zeiffer B, Lefton D (2002) Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. Brain 125(Pt 4):812–822CrossRefPubMed
26.
Zurück zum Zitat Fazzone HE, Lefton DR, Kupersmith MJ (2003) Optic neuritis: correlation of pain and magnetic resonance imaging. Ophthalmology 110(8):1646–1649CrossRefPubMed Fazzone HE, Lefton DR, Kupersmith MJ (2003) Optic neuritis: correlation of pain and magnetic resonance imaging. Ophthalmology 110(8):1646–1649CrossRefPubMed
27.
Zurück zum Zitat Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG (2006) Brain abnormalities in neuromyelitis optica. Arch Neurol 63(3):390–396CrossRefPubMed Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG (2006) Brain abnormalities in neuromyelitis optica. Arch Neurol 63(3):390–396CrossRefPubMed
28.
Zurück zum Zitat Lemos MD, Carvalho GB, Carvalho RS, Bichuetti DB, de Oliveira EM, Abdala N (2015) Neuromyelitis optica spectrum disorders: beyond longitudinally extensive transverse myelitis. Clin Radiol 70(6):630–637CrossRefPubMed Lemos MD, Carvalho GB, Carvalho RS, Bichuetti DB, de Oliveira EM, Abdala N (2015) Neuromyelitis optica spectrum disorders: beyond longitudinally extensive transverse myelitis. Clin Radiol 70(6):630–637CrossRefPubMed
29.
Zurück zum Zitat Kim HJ, Paul F, Lana-Peixoto MA et al (2015) MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology 84(11):1165–1173CrossRefPubMedPubMedCentral Kim HJ, Paul F, Lana-Peixoto MA et al (2015) MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology 84(11):1165–1173CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Matthews L, Marasco R, Jenkinson M et al (2013) Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology 80(14):1330–1337CrossRefPubMedPubMedCentral Matthews L, Marasco R, Jenkinson M et al (2013) Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution. Neurology 80(14):1330–1337CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Huh SY, Min JH, Kim W et al (2014) The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders. Mult Scler 20(6):695–704CrossRefPubMed Huh SY, Min JH, Kim W et al (2014) The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders. Mult Scler 20(6):695–704CrossRefPubMed
32.
Zurück zum Zitat Tintoré M, Rovira A, Rio J et al (2005) Isoptic neuritis more benign than other first attacks in multiple sclerosis? Ann Neurol 57(2):210–215CrossRefPubMed Tintoré M, Rovira A, Rio J et al (2005) Isoptic neuritis more benign than other first attacks in multiple sclerosis? Ann Neurol 57(2):210–215CrossRefPubMed
33.
Zurück zum Zitat Optic neuritis study group (2008) Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 65(6):727–732 Optic neuritis study group (2008) Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol 65(6):727–732
34.
Zurück zum Zitat Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology. 53(5):1107–1114CrossRefPubMed Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology. 53(5):1107–1114CrossRefPubMed
35.
Zurück zum Zitat Zhou H, Zhao S, Yin D et al (2016) Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages. J Neurol 263(7):1382–1389CrossRefPubMed Zhou H, Zhao S, Yin D et al (2016) Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages. J Neurol 263(7):1382–1389CrossRefPubMed
36.
Zurück zum Zitat Kitley J, Leite MI, Nakashima I et al (2012) Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain 135(Pt 6):1834–1849CrossRefPubMed Kitley J, Leite MI, Nakashima I et al (2012) Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. Brain 135(Pt 6):1834–1849CrossRefPubMed
37.
Zurück zum Zitat Costa C, Arrambide G, Tintore M et al (2012) Value of NMO-IgG determination at the time of presentation as CIS. Neurology 78(20):1608–1611CrossRefPubMed Costa C, Arrambide G, Tintore M et al (2012) Value of NMO-IgG determination at the time of presentation as CIS. Neurology 78(20):1608–1611CrossRefPubMed
38.
Zurück zum Zitat Petzold A, Pittock S, Lennon V, Maggiore C, Weinshenker BG, Plant GT (2010) Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry 81(1):109–111. doi:10.1136/jnnp.2008.146894 CrossRefPubMed Petzold A, Pittock S, Lennon V, Maggiore C, Weinshenker BG, Plant GT (2010) Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry 81(1):109–111. doi:10.​1136/​jnnp.​2008.​146894 CrossRefPubMed
39.
Zurück zum Zitat Kim SM, Woodhall MR, Kim JS et al (2015) Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS. Neurol Neuroimmunol Neuroinflamm 2(6):e163CrossRefPubMedPubMedCentral Kim SM, Woodhall MR, Kim JS et al (2015) Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS. Neurol Neuroimmunol Neuroinflamm 2(6):e163CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Zamvil SS, Slavin AJ (2015) Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? Neurol Neuroimmunol Neuroinflamm 2(1):e62CrossRefPubMedPubMedCentral Zamvil SS, Slavin AJ (2015) Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? Neurol Neuroimmunol Neuroinflamm 2(1):e62CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Sepúlveda M, Armangué T, Sola-Valls N et al (2016) Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus. Neurol Neuroimmunol Neuroinflamm 3(3):e225CrossRefPubMedPubMedCentral Sepúlveda M, Armangué T, Sola-Valls N et al (2016) Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus. Neurol Neuroimmunol Neuroinflamm 3(3):e225CrossRefPubMedPubMedCentral
Metadaten
Titel
Combined brain and anterior visual pathways’ MRIs assist in early identification of neuromyelitis optica spectrum disorder at onset of optic neuritis
verfasst von
D. Buch
J. Savatovsky
O. Gout
C. Vignal
R. Deschamps
Publikationsdatum
01.11.2016
Verlag
Springer International Publishing
Erschienen in
Acta Neurologica Belgica / Ausgabe 1/2017
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-016-0714-2

Weitere Artikel der Ausgabe 1/2017

Acta Neurologica Belgica 1/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.